Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02521103 · ClinicalTrials.gov registry record · NA

Triathlon Tritanium Cone Augments Outcomes Study

A NA study of Arthroplasty and Replacement, sponsored by Stryker Orthopaedics.

Active
Registry status
NA
Development phase
145
Enrollment target
9
Study locations

NCT02521103 is a NA study of Arthroplasty and Replacement that is active but no longer recruiting, run by Stryker Orthopaedics. The registered enrollment target is 145 participants, below the 212-participant average among 5 other Arthroplasty trials with a reported enrollment target (32% lower). The trial reports 9 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02521103, a NA study of Arthroplasty and Replacement, is active but no longer recruiting, sponsored by Stryker Orthopaedics.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
145 participants
Enrollment target
9
Study locations

Study Summary

This study is a prospective, open-label, post-market, non-randomized, multi-center clinical evaluation of the Triathlon TS Total Knee System with Triathlon Tritanium Cone Augments for revision total knee arthroplasty (TKA) in a consecutive series of patients who meet the eligibility criteria. The revision rate of the Triathlon Tritanium Cone Augments is expected to be less than 2.8% for aseptic loosening of either the Femoral or the Tibial Cone Augments at 2 years postoperative.

Conditions Studied

Arthroplasty Replacement Knee

Interventions

  • DEVICE Triathlon Tritanium Cone Augments

Study Locations (9)

Michigan

  • The CORE Institute - Novi
  • Michigan Heart, St. Joseph Health System - Ypsilanti

Florida

  • Florida Medical Clinic - Zephyrhills

Illinois

  • Rush University Medical Center - Chicago

Kentucky

  • Bluegrass Orthopaedics - Lexington

Missouri

  • Missouri Orthopaedic Institute - Columbia

New Jersey

  • Rothman Institute - Egg Harbor

Oklahoma

  • The Orthopaedic Center - Tulsa

Washington

  • Providence Medical Research Center - Spokane

Trial Details

FieldValue
Enrollment Target 145 participants
Start Date 2015-08
Est. Completion 2028-03-31
Phase NA

Sponsor

Stryker Orthopaedics

27 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02521103

The ClinicalTrials.gov registry entry for NCT02521103 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 212-participant average among 5 other Arthroplasty trials with a reported enrollment target (32% lower). The listed sponsor is Stryker Orthopaedics, which has 27 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Arthroplasty appearing as the primary indexed condition, and to 1 intervention - of which Triathlon Tritanium Cone Augments is the first listed.

NCT02521103 reports 9 study locations spanning 8 distinct geographic areas - top geographies include Michigan, Florida, Illinois.

Frequently Asked Questions

What is clinical trial NCT02521103 about?

NCT02521103 is a clinical study titled "Triathlon Tritanium Cone Augments Outcomes Study". This study is a prospective, open-label, post-market, non-randomized, multi-center clinical evaluation of the Triathlon TS Total Knee System with Triathlon Tritanium Cone Augments for revision total knee arthroplasty (TKA) in a consecutive series of patients who meet the eligibility criteria. The re...

What is the current status of trial NCT02521103?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 145 participants. The study started on 2015-08. Estimated completion is 2028-03-31.

What conditions does trial NCT02521103 study?

This clinical trial studies the following conditions: Arthroplasty, Replacement, Knee.

What interventions are being tested in trial NCT02521103?

The interventions under investigation include: Triathlon Tritanium Cone Augments (DEVICE).

Who is sponsoring clinical trial NCT02521103?

This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02521103 being conducted?

This trial has 9 study locations across Florida, Illinois, Kentucky, Michigan, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Arthroplasty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Arthroplasty

All registered trials for this condition

Replacement

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.